VCYTVeracyte, Inc.

CSNasdaq (XNAS)·USD

Identity

Security key: 23261
Ticker: VCYT
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2013-10-30
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: VCYT

Detail

Enriched 2026-08-14 20:47

Market cap: $3,591,857,861.08
Shares outstanding (class): 80,390,731
Shares outstanding (weighted): 80,390,731
SIC: 8071 SERVICES-MEDICAL LABORATORIES
Employees: 755
Location: SOUTH SAN FRANCISCO, CA
Homepage: https://www.veracyte.com
Description: Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Market cap and share counts drift.

Funds holding this security

171 funds · 173 positions · $970.78M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Core S&P Small-Cap ETF iShares Trust	IJR	$152.86M	0.17%	4,745,733 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$80.85M	0.00%	2,510,050 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$63.06M	0.85%	1,957,681 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$61.80M	0.09%	1,918,736 NS	FIGI
First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund	FBT	$61.79M	2.72%	1,918,341 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$59.07M	0.04%	1,833,976 NS	FIGI
Artisan Mid Cap Fund Artisan Partners Funds Inc.	—	$40.83M	1.38%	1,267,576 NS	FIGI
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$33.01M	0.09%	1,024,699 NS	FIGI
FULLERTHALER BEHAVIORAL SMALL-CAP GROWTH Capitol Series Trust	—	$30.43M	0.72%	944,700 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$28.38M	0.03%	881,118 NS	FIGI
Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust	—	$28.12M	0.30%	873,092 NS	FIGI
State Street(R) SPDR(R) Portfolio S&P 600(TM) S… SPDR SERIES TRUST	SPSM	$23.02M	0.17%	714,824 NS	FIGI
iShares S&P Small-Cap 600 Growth ETF iShares Trust	IJT	$21.97M	0.34%	682,014 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$20.53M	0.17%	637,363 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$18.66M	0.23%	579,343 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERVCYT
FIGI_COMPOSITEBBG001J2M542
FIGI_SHARE_CLASSBBG001TSQWW0
CIK0001384101
ISINUS92337F1075
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Health Care Providers
Source: LLMunreviewed
Self-reported confidence: 0.9
Model: deepseek
Rationale: Veracyte is a molecular diagnostics company providing genomic testing services, fitting under healthcare providers.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.